First-trimester nonsystemic corticosteroid use and the risk of oral clefts in Norway

Annals of Epidemiology

Volumn 24, Issue 9, 2014, Pages 635-640

  Skuladottir, Hildur ^a,b   Wilcox, Allen ^c   McConnaughey, Robert ^d   Vindenes, Hallvard ^a   Lie, Rolv T ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d WESTAT   (United States)

Author keywords

Cleft lip; Cleft palate; Corticosteroids; Maternal exposure; Moba; Pregnancy

Indexed keywords

CORTICOSTEROID; DERMATOLOGICAL AGENT;

ARTICLE; CASE CONTROL STUDY; CLEFT LIP; CLEFT PALATE; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG USE; ENVIRONMENTAL EXPOSURE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NORWAY; PLACENTAL TRANSFER; PRIORITY JOURNAL; PROGENY; QUESTIONNAIRE; RISK ASSESSMENT; SKIN ABSORPTION;

CLEFT LIP; CLEFT PALATE; CORTICOSTEROIDS; MATERNAL EXPOSURE; MOBA; PREGNANCY;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; CASE-CONTROL STUDIES; CLEFT LIP; CLEFT PALATE; CONFIDENCE INTERVALS; FEMALE; HUMANS; LOGISTIC MODELS; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; NORWAY; ODDS RATIO; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL EXPOSURE DELAYED EFFECTS; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84905977219     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2014.06.005     Document Type: Article

References (42)

1. Fraser F.C., Fainstat T.D. Production of congenital defects in the offspring of pregnant mice treated with cortisone: progress report. Pediatrics 1951, 8(4):527-533.
2. Walker B.E., Fraser F.C. The embryology of cortisone-induced cleft palate. JEmbryol Exp Morphol 1957, 5(2):201-209.
3. Carmichael S.L., Shaw G.M. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet 1999, 86(3):242-244.
4. Carmichael S.L., Shaw G.M., Ma C., Werler M.M., Rasmussen S.A., Lammer E.J. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007, 197(6):585.e1-585.e7.
5. Källén B. Maternal drug use and infant cleft lip/palate with special reference to corticoids. Cleft Palate-Craniofacial J 2003, 40(6):624-628.
6. Edwards M.J., Agho K., Attia J., Diaz P., Hayes T., Illingworth A., et al. Case-control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy. Am J Med Genet Part A 2003, 120A(4):459-463.
7. Czeizel A.E., Hirschberg J. Orofacial clefts in Hungary. Epidemiological and genetic data, primary prevention. Folia Phoniatr Logop 1997, 49(3-4):111-116. PubMed PMID: 9256533. Epub 1997/01/01. eng.
8. Pradat P., Robert-Gnansia E., Di Tanna G.L., Rosano A., Lisi A., Mastroiacovo P. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res Part A: Clin Mol Teratology 2003, 67(12):968-970.
9. Rodríguez-Pinilla E., Luisa Martínez-Frías M. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology 1998, 58(1):2-5.
10. Hviid A., Mølgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ 2011, 183(7):796-804.
11. Chi C.-C., Wang S.-H., Kirtschig G., Wojnarowska F. Systematic review of the safety of topical corticosteroids in pregnancy. JAm Acad Dermatol 2010, 62(4):694-705.
12. Wilcox A.J., Lie R.T., Solvoll K., Taylor J., McConnaughey D.R., Abyholm F., et al. Folic acid supplements and risk of facial clefts: national population based case-control study. Br Med J 2007, 334(7591):464-467. PubMed PMID: ISI:000244802000033. English.
13. Lie R.T., Wilcox A.J., Taylor J., Gjessing H.K., Saugstad O.D., Aabyholm F., et al. Maternal smoking and oral clefts - the role of detoxification pathway genes. Epidemiology 2008, 19(4):606-615. PubMed PMID: ISI:000256865100017. English.
14. Nilsen R.M., Vollset S.E., Gjessing H.K., Skjaerven R., Melve K.K., Schreuder P., et al. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol 2009, 23(6):597-608. PubMed PMID: 19840297. Epub 2009/10/21. eng.
15. Magnus P., Irgens L.M., Haug K., Nystad W., Skjærven R., Stoltenberg C., et al. Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol 2006, 35(5):1146-1150.
16. NIEHS. Available at:. http://www.niehs.nih.gov/research/atniehs/labs/epi/studies/ncl/question/index.cfm.
17. Sperber GH. Formation of the primary palate and palatogenesis: closure of the secondary palate. 2002:5-24.
18. WHO. ATC system:. http://www.whocc.no/atc_ddd_index/.
19. The Norwegian Institute of Public Health. Available at:. http://www.fhi.no/dokumenter/1f32a49514.pdf.
20. Kubon C., Sivertsen Å., Andreas Vindenes H., Åbyholm F., Wilcox A., Terje Lie R. Completeness of registration of oral clefts in a medical birth registry: a population-based study. Acta Obstetricia Gynecologica Scand 2007, 86(12):1453-1457.
21. Tanaka S., Mizorogi T., Nishijima K., Kuwahara S., Tsujio M., Aoyama H., et al. Body and major organ weights of A/J-Chr 11(SM) consomic mice. Exp Anim 2009, 58(4):357-361. PubMed PMID: 19654433. Epub 2009/08/06. eng.
22. PDR.net. http://www.pdr.net/drug-summary/prednisolone-tablets?druglabelid=2138%26id=900.
23. Carmichael S.L., Shaw G.M., Yang W., Abrams B., Lammer E.J. Maternal stressful life events and risks of birth defects. Epidemiology 2007, 18(3):356-361. PubMed PMID: 17435445. Pubmed Central PMCID: 2094125. Epub 2007/04/17. eng.
24. Ingstrup K.G., Liang H., Olsen J., Nohr E.A., Bech B.H., Wu C.S., et al. Maternal bereavement in the antenatal period and oral cleft in the offspring. Hum Reprod 2013, 28:1092-1099. PubMed PMID: 23293222. Epub 2013/01/08. Eng.
25. Carmichael S.L., Shaw G.M., Ma C., Werler M.M., Rasmussen S.A., Lammer E.J. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007, 197(6):585. e1-7. discussion 683-4, e1-7. PubMed PMID: 18060943. Epub 2007/12/07. eng.
26. Olesen C., Søndergaard C., Thrane N., Lauge Nielsen G., de Jong-van den Berg L., Olsen J., et al. Do pregnant women report use of dispensed medications?. Epidemiology 2001, 12(5):497-501.
27. Lam J., Polifka J.E., Dohil M.A. Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases. JAm Acad Dermatol 2008, 59(2):295-315.
28. Hengge U.R., Ruzicka T., Schwartz R.A., Cork M.J. Adverse effects of topical glucocorticosteroids. JAm Acad Dermatol 2006, 54(1):1-15.
29. Habif T.P. Clinical dermatology: a color guide to diagnosis and therapy 1990, Mosby, St. Louis. 2nd ed.
30. Feldmann R.J., Maibach H.I. Regional variation in percutaneous penetration of 14C cortisol in Man1. JInvest Dermatol 1967, 48(2):181-183.
31. Turpeinen M., Lehtokoski-Lehtiniemi E., Leisti S., Salo O.P. Percutaneous absorption of hydrocortisone during and after the acute phase of dermatitis in children. Pediatr Dermatol 1988, 5(4):276-279.
32. Yamada H., Nakano M., Ichihashi T. Fetal concentration after topical application of betamethasone 17,21-dipropionate (S-3440) ointment and teratogenesis in mice and rabbits. Pharmacometrics 1981, 21(4):645-655.
33. Seckl J.R. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 2004, 151(Suppl 3):U49-U62.
34. Benediktsson R., Calder A.A., Edwards C.R.W., Seckl J.R. Placental 11β-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol 1997, 46(2):161-166.
35. Crowley P. Prophylactic corticosteroids for preterm birth (Withdrawn Paper. 2006, art no. CD000065). Cochrane Db Syst Rev. 2006 (3). PubMed PMID: ISI:000239141400174. English.
36. Gitau R., Cameron A., Fisk N.M., Glover V. Fetal exposure to maternal cortisol. Lancet 1998, 352(9129):707-708.
37. Walker A.M. Confounding by indication. Epidemiology 1996, 7(4):335-336. PubMed PMID: 8793355. Epub 1996/07/01. eng.
38. Wilkins I., Loy G., Rogers D., Chor J., To M.-L., Velez B. Maternal corticosteroid use and orofacial clefts: a study by Carmichael etal. Am J Obstet Gynecol 2007, 197(6):683-684.
39. Ingraham C.R., Kinoshita A., Kondo S., Yang B., Sajan S., Trout K.J., et al. Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nat Genet 2006, 38(11):1335-1340.
40. Richardson R.J., Dixon J., Malhotra S., Hardman M.J., Knowles L., Boot-Handford R.P., et al. Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch. Nat Genet 2006, 38(11):1329-1334.
41. Zucchero T.M., Cooper M.E., Maher B.S., Daack-Hirsch S., Nepomuceno B., Ribeiro L., et al. Interferon regulatory factor 6 (IRF6) gene variants and the risk of isolated cleft lip or palate. New Engl J Med 2004, 351(8):769-780. PubMed PMID: 15317890.
42. Walker B.E. Induction of cleft palate in rats with antiinflammatory drugs. Teratology 1971, 4(1):39-42.